{"id":"NCT01368276","sponsor":"BioVex Limited","briefTitle":"An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma","officialTitle":"An Extension Protocol to Evaluate the Efficacy and Safety of Extended Use Treatment With OncoVEX^GM-CSF for Eligible Melanoma Patients Participating in Study 005/05","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-10","primaryCompletion":"2014-09","completion":"2014-09","firstPosted":"2011-06-07","resultsPosted":"2015-12-18","lastUpdate":"2015-12-18"},"enrollment":31,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Melanoma"],"interventions":[{"type":"BIOLOGICAL","name":"Talimogene Laherparepvec","otherNames":["OncoVEX^GM-CSF","IMLYGICâ„¢"]},{"type":"DRUG","name":"Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF)","otherNames":[]}],"arms":[{"label":"GM-CSF","type":"ACTIVE_COMPARATOR"},{"label":"Talimogene Laherparepvec","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to learn about the safety and the risks of using talimogene laherparepvec in patients who already received treatment with talimogene laherparepvec in study 005/05 (NCT00769704), and to see if extended treatment with talimogene laherparepvec can destroy melanoma tumors.","primaryOutcome":{"measure":"Number of Participants With Treatment-emergent Adverse Events (AEs)","timeFrame":"From first administration of study drug in the extension period until 30 days after last dose. Median duration of treatment was 50 weeks in the GM-CSF group and 36 weeks in the talimogene laherparepvec group.","effectByArm":[{"arm":"GM-CSF","deltaMin":3,"sd":null},{"arm":"Talimogene Laherparepvec","deltaMin":26,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":10,"countries":["United States","United Kingdom"]},"refs":{"pmids":[],"seeAlso":["http://www.biovex.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":3},"commonTop":["Chills","Pyrexia","Diarrhoea","Fatigue","Vomiting"]}}